Current position:Home >Product >
Formamide, N-[1-[2-(3,4-dihydroxyphenyl)ethyl]-2,5-dioxo-3-pyrrolidinyl]-, (S)-
Formamide, N-[1-[2-(3,4-dihydroxyphenyl)ethyl]-2,5-dioxo-3-pyrrolidinyl]-, (S)-(66157-28-6)
- Name: Formamide, N-[1-[2-(3,4-dihydroxyphenyl)ethyl]-2,5-dioxo-3-pyrrolidinyl]-, (S)-
- Synonyms:
- Molecular Formula:C13H14N2O5
- Molecular Weight:
- CAS Registry Number:66157-28-6
- EINECS:
- Melting Point:
- Water Solubility:

Other Product
- 66156-95-4/L-Serine, N-glycyl-, ethyl ester
- 66156-96-5/Glycine, N-[N-[(1,1-dimethylethoxy)carbonyl]-S-(1,1-dimethylethyl)-L-cysteinyl]-, methyl ester
- 66156-97-6/Glycine, N-[N-[N-[(phenylmethoxy)carbonyl]glycyl]-L-cysteinyl]-, methyl ester
- 66156-98-7/L-Cysteine, S-[(4-methoxyphenyl)methyl]-, 1,1-dimethylethyl ester
- 66156-99-8/L-Cysteine, S-[(4-methoxyphenyl)methyl]-, 1,1-dimethylethyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- 66157-01-5/L-Threonine, N-[[(4-nitrophenyl)methoxy]carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
- 66157-03-7/L-Serine, N-[N-[N-[N-[[(4-nitrophenyl)methoxy]carbonyl]-L-threonyl]-L-phenylalanyl]- L-threonyl]-, methyl ester
- 66157-04-8/L-Serine, N-[N-[N-[N-[[(4-nitrophenyl)methoxy]carbonyl]-L-threonyl]-L-phenylalanyl]- L-threonyl]-, hydrazide
- 66157-13-9/L-Aspartic acid, N-acetyl-, 1-(4-nitrophenyl) 4-(phenylmethyl) ester
- 66157-14-0/Butanoic acid, 3-(acetylamino)-4-[[2-(3,4-dihydroxyphenyl)ethyl]amino]-4-oxo-, phenylmethyl ester, (S)-
- 66157-15-1/Butanoic acid, 3-(acetylamino)-4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxo-, phenylmethyl ester, (S)-
- 66157-16-2/Acetamide, N-[1-[2-(3,4-dihydroxyphenyl)ethyl]-2,5-dioxo-3-pyrrolidinyl]-, (S)-
- 66157-17-3/Butanoic acid, 3-(acetylamino)-4-[[2-(3,4-dihydroxyphenyl)ethyl]amino]-4-oxo-, (S)-
- 66157-18-4/Butanoic acid, 3-(acetylamino)-4-[[2-(3,4-dihydroxyphenyl)ethyl]amino]-4-oxo-, methyl ester, (S)-
- 66157-20-8/Butanediamide, 2-(acetylamino)-N,N'-bis[2-(3,4-dihydroxyphenyl)ethyl]-, (S)-
- 66157-21-9/Acetamide, N-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carb onyl]-3-oxopropyl]-, (S)-
- 66157-23-1/Butanoic acid, 3-(acetylamino)-4-[[2-(5-hydroxy-1H-indol-3-yl)ethyl]amino]-4-oxo-, phenylmethyl ester, (S)-
- 66157-24-2/Acetamide, N-[1-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-2,5-dioxo-3-pyrrolidinyl]-, (S)-
- 66157-27-5/Butanoic acid, 4-[[2-(3,4-dihydroxyphenyl)ethyl]amino]-3-(formylamino)-4-oxo-, phenylmethyl ester, (S)-
- 66157-28-6/Formamide, N-[1-[2-(3,4-dihydroxyphenyl)ethyl]-2,5-dioxo-3-pyrrolidinyl]-, (S)-
- 66157-32-2/Carbamic acid, [1-[2-(3,4-dihydroxyphenyl)ethyl]-2,5-dioxo-3-pyrrolidinyl]-, phenylmethyl ester, (S)-
- 66157-33-3/2,5-Pyrrolidinedione, 3-amino-1-[2-(3,4-dihydroxyphenyl)ethyl]-, (S)-
- 66157-34-4/Butanoic acid, 3-(acetylamino)-4-oxo-4-(propylamino)-, phenylmethyl ester, (S)-
- 66157-35-5/Butanoic acid, 3-(acetylamino)-4-oxo-4-(propylamino)-, (S)-
- 66157-54-8/1-Piperidineacetamide, N-2-thiazolyl-
- 66157-55-9/1-Piperidineacetamide, N-2-benzothiazolyl-
- 66157-56-0/5-Hexenoic acid, 2-amino-5-chloro-
- 66157-57-1/9H-Xanthen-9-one, 1,3,4,5,8-pentamethoxy-
- 66157-58-2/9H-Xanthen-9-one, 1,2,5,6,8-pentamethoxy-
- 66157-66-2/Acetamide, 2-(hydroxyimino)-N,N-dimethyl-2-(methylsulfinyl)-